nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—SLCO1B3—Mycophenolate mofetil—systemic scleroderma	0.0898	0.144	CbGbCtD
Paclitaxel—ABCG2—Leflunomide—systemic scleroderma	0.0673	0.108	CbGbCtD
Paclitaxel—ABCC10—Methotrexate—systemic scleroderma	0.0645	0.103	CbGbCtD
Paclitaxel—CYP2C8—Mometasone—systemic scleroderma	0.0556	0.089	CbGbCtD
Paclitaxel—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.046	0.0736	CbGbCtD
Paclitaxel—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0416	0.0665	CbGbCtD
Paclitaxel—SLCO1B3—Methotrexate—systemic scleroderma	0.036	0.0577	CbGbCtD
Paclitaxel—ABCB1—Lisinopril—systemic scleroderma	0.0254	0.0407	CbGbCtD
Paclitaxel—CYP2C9—Leflunomide—systemic scleroderma	0.025	0.04	CbGbCtD
Paclitaxel—ABCC1—Methotrexate—systemic scleroderma	0.0249	0.0399	CbGbCtD
Paclitaxel—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.023	0.0369	CbGbCtD
Paclitaxel—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0221	0.0354	CbGbCtD
Paclitaxel—ABCB1—Captopril—systemic scleroderma	0.019	0.0305	CbGbCtD
Paclitaxel—ABCC2—Methotrexate—systemic scleroderma	0.0184	0.0295	CbGbCtD
Paclitaxel—ABCG2—Methotrexate—systemic scleroderma	0.0167	0.0267	CbGbCtD
Paclitaxel—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.015	0.024	CbGbCtD
Paclitaxel—ABCB1—Prednisone—systemic scleroderma	0.012	0.0192	CbGbCtD
Paclitaxel—CYP2C9—cardial valve—systemic scleroderma	0.00919	0.116	CbGeAlD
Paclitaxel—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00898	0.0144	CbGbCtD
Paclitaxel—CYP3A4—Prednisone—systemic scleroderma	0.00718	0.0115	CbGbCtD
Paclitaxel—ABCB1—Methotrexate—systemic scleroderma	0.00601	0.00962	CbGbCtD
Paclitaxel—NR1I2—digestive system—systemic scleroderma	0.00238	0.03	CbGeAlD
Paclitaxel—TUBB3—connective tissue—systemic scleroderma	0.00215	0.0272	CbGeAlD
Paclitaxel—MAP4—connective tissue—systemic scleroderma	0.00215	0.0272	CbGeAlD
Paclitaxel—BCL2—connective tissue—systemic scleroderma	0.00196	0.0247	CbGeAlD
Paclitaxel—MAP4—skin of body—systemic scleroderma	0.00194	0.0245	CbGeAlD
Paclitaxel—MAPT—tendon—systemic scleroderma	0.00188	0.0238	CbGeAlD
Paclitaxel—BCL2—smooth muscle tissue—systemic scleroderma	0.00179	0.0226	CbGeAlD
Paclitaxel—BCL2—skin of body—systemic scleroderma	0.00177	0.0223	CbGeAlD
Paclitaxel—TUBB3—digestive system—systemic scleroderma	0.00156	0.0196	CbGeAlD
Paclitaxel—MAP4—digestive system—systemic scleroderma	0.00156	0.0196	CbGeAlD
Paclitaxel—MAP4—tendon—systemic scleroderma	0.00148	0.0187	CbGeAlD
Paclitaxel—BCL2—digestive system—systemic scleroderma	0.00141	0.0178	CbGeAlD
Paclitaxel—TUBB4A—connective tissue—systemic scleroderma	0.00131	0.0165	CbGeAlD
Paclitaxel—MAP4—lung—systemic scleroderma	0.0013	0.0164	CbGeAlD
Paclitaxel—TUBB3—lung—systemic scleroderma	0.0013	0.0164	CbGeAlD
Paclitaxel—TUBB2B—connective tissue—systemic scleroderma	0.00127	0.016	CbGeAlD
Paclitaxel—MAP2—digestive system—systemic scleroderma	0.00122	0.0155	CbGeAlD
Paclitaxel—TUBB2A—connective tissue—systemic scleroderma	0.00119	0.015	CbGeAlD
Paclitaxel—TUBB4A—skin of body—systemic scleroderma	0.00118	0.0149	CbGeAlD
Paclitaxel—BCL2—lung—systemic scleroderma	0.00118	0.0149	CbGeAlD
Paclitaxel—ABCB11—digestive system—systemic scleroderma	0.00117	0.0148	CbGeAlD
Paclitaxel—MAP2—tendon—systemic scleroderma	0.00117	0.0147	CbGeAlD
Paclitaxel—SLCO1B3—lung—systemic scleroderma	0.00114	0.0143	CbGeAlD
Paclitaxel—TUBB—smooth muscle tissue—systemic scleroderma	0.0011	0.0138	CbGeAlD
Paclitaxel—TUBB2A—smooth muscle tissue—systemic scleroderma	0.00109	0.0138	CbGeAlD
Paclitaxel—TUBB2A—skin of body—systemic scleroderma	0.00108	0.0136	CbGeAlD
Paclitaxel—TUBB6—smooth muscle tissue—systemic scleroderma	0.00108	0.0136	CbGeAlD
Paclitaxel—TUBB6—skin of body—systemic scleroderma	0.00106	0.0134	CbGeAlD
Paclitaxel—MAP2—lung—systemic scleroderma	0.00102	0.0129	CbGeAlD
Paclitaxel—TUBB4B—connective tissue—systemic scleroderma	0.00102	0.0129	CbGeAlD
Paclitaxel—TUBB4A—digestive system—systemic scleroderma	0.000946	0.0119	CbGeAlD
Paclitaxel—TUBB4B—smooth muscle tissue—systemic scleroderma	0.000935	0.0118	CbGeAlD
Paclitaxel—TUBB4B—skin of body—systemic scleroderma	0.000923	0.0116	CbGeAlD
Paclitaxel—TUBB2B—digestive system—systemic scleroderma	0.000915	0.0115	CbGeAlD
Paclitaxel—TUBB4A—tendon—systemic scleroderma	0.000901	0.0114	CbGeAlD
Paclitaxel—TUBB2B—tendon—systemic scleroderma	0.000871	0.011	CbGeAlD
Paclitaxel—CYP19A1—connective tissue—systemic scleroderma	0.000866	0.0109	CbGeAlD
Paclitaxel—TUBB2A—digestive system—systemic scleroderma	0.000861	0.0109	CbGeAlD
Paclitaxel—TUBB6—digestive system—systemic scleroderma	0.000849	0.0107	CbGeAlD
Paclitaxel—TUBB—tendon—systemic scleroderma	0.000824	0.0104	CbGeAlD
Paclitaxel—TUBB2A—tendon—systemic scleroderma	0.000819	0.0103	CbGeAlD
Paclitaxel—CYP1B1—connective tissue—systemic scleroderma	0.00081	0.0102	CbGeAlD
Paclitaxel—TUBB6—tendon—systemic scleroderma	0.000808	0.0102	CbGeAlD
Paclitaxel—TUBB4A—lung—systemic scleroderma	0.00079	0.00997	CbGeAlD
Paclitaxel—TUBB2B—lung—systemic scleroderma	0.000764	0.00964	CbGeAlD
Paclitaxel—ABCC10—digestive system—systemic scleroderma	0.000744	0.00938	CbGeAlD
Paclitaxel—CYP1B1—smooth muscle tissue—systemic scleroderma	0.000741	0.00934	CbGeAlD
Paclitaxel—TUBB4B—digestive system—systemic scleroderma	0.000738	0.00931	CbGeAlD
Paclitaxel—CYP1B1—skin of body—systemic scleroderma	0.000731	0.00922	CbGeAlD
Paclitaxel—TUBB—lung—systemic scleroderma	0.000723	0.00912	CbGeAlD
Paclitaxel—TUBB2A—lung—systemic scleroderma	0.000719	0.00907	CbGeAlD
Paclitaxel—TUBB6—lung—systemic scleroderma	0.000709	0.00895	CbGeAlD
Paclitaxel—ABCC10—tendon—systemic scleroderma	0.000708	0.00893	CbGeAlD
Paclitaxel—TUBB4B—tendon—systemic scleroderma	0.000703	0.00886	CbGeAlD
Paclitaxel—ABCC10—lung—systemic scleroderma	0.000621	0.00784	CbGeAlD
Paclitaxel—TUBB4B—lung—systemic scleroderma	0.000617	0.00778	CbGeAlD
Paclitaxel—ABCC2—digestive system—systemic scleroderma	0.000597	0.00753	CbGeAlD
Paclitaxel—CYP1B1—digestive system—systemic scleroderma	0.000585	0.00738	CbGeAlD
Paclitaxel—ABCB1—blood vessel—systemic scleroderma	0.00058	0.00732	CbGeAlD
Paclitaxel—ABCC2—tendon—systemic scleroderma	0.000568	0.00717	CbGeAlD
Paclitaxel—CYP1B1—tendon—systemic scleroderma	0.000556	0.00702	CbGeAlD
Paclitaxel—ABCC1—tendon—systemic scleroderma	0.0005	0.00632	CbGeAlD
Paclitaxel—CYP1B1—lung—systemic scleroderma	0.000488	0.00616	CbGeAlD
Paclitaxel—ABCC1—lung—systemic scleroderma	0.000439	0.00554	CbGeAlD
Paclitaxel—CYP3A5—digestive system—systemic scleroderma	0.000404	0.0051	CbGeAlD
Paclitaxel—CYP2C9—digestive system—systemic scleroderma	0.000398	0.00502	CbGeAlD
Paclitaxel—ABCG2—lung—systemic scleroderma	0.000364	0.00459	CbGeAlD
Paclitaxel—CYP3A5—lung—systemic scleroderma	0.000338	0.00426	CbGeAlD
Paclitaxel—CYP3A4—digestive system—systemic scleroderma	0.000303	0.00383	CbGeAlD
Paclitaxel—ABCB1—digestive system—systemic scleroderma	0.000215	0.00271	CbGeAlD
Paclitaxel—ABCB1—lung—systemic scleroderma	0.000179	0.00226	CbGeAlD
Paclitaxel—Myocardial infarction—Prednisone—systemic scleroderma	0.000103	0.000348	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000103	0.000348	CcSEcCtD
Paclitaxel—Breast disorder—Methotrexate—systemic scleroderma	0.000103	0.000348	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000103	0.000347	CcSEcCtD
Paclitaxel—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000347	CcSEcCtD
Paclitaxel—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000103	0.000346	CcSEcCtD
Paclitaxel—Hypersensitivity—Azathioprine—systemic scleroderma	0.000102	0.000346	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000102	0.000346	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000346	CcSEcCtD
Paclitaxel—Insomnia—Lisinopril—systemic scleroderma	0.000102	0.000345	CcSEcCtD
Paclitaxel—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000344	CcSEcCtD
Paclitaxel—Paraesthesia—Lisinopril—systemic scleroderma	0.000101	0.000342	CcSEcCtD
Paclitaxel—Vomiting—Captopril—systemic scleroderma	0.000101	0.000342	CcSEcCtD
Paclitaxel—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000101	0.000341	CcSEcCtD
Paclitaxel—Dyspnoea—Lisinopril—systemic scleroderma	0.000101	0.00034	CcSEcCtD
Paclitaxel—Rash—Captopril—systemic scleroderma	0.0001	0.000339	CcSEcCtD
Paclitaxel—Dermatitis—Captopril—systemic scleroderma	0.0001	0.000339	CcSEcCtD
Paclitaxel—Somnolence—Lisinopril—systemic scleroderma	0.0001	0.000339	CcSEcCtD
Paclitaxel—Headache—Captopril—systemic scleroderma	9.99e-05	0.000337	CcSEcCtD
Paclitaxel—Confusional state—Mycophenolate mofetil—systemic scleroderma	9.97e-05	0.000337	CcSEcCtD
Paclitaxel—Dyspepsia—Lisinopril—systemic scleroderma	9.94e-05	0.000335	CcSEcCtD
Paclitaxel—Abdominal pain—Mycophenolic acid—systemic scleroderma	9.91e-05	0.000334	CcSEcCtD
Paclitaxel—Body temperature increased—Mycophenolic acid—systemic scleroderma	9.91e-05	0.000334	CcSEcCtD
Paclitaxel—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	9.89e-05	0.000334	CcSEcCtD
Paclitaxel—Oedema—Mycophenolate mofetil—systemic scleroderma	9.89e-05	0.000334	CcSEcCtD
Paclitaxel—Infection—Mycophenolate mofetil—systemic scleroderma	9.83e-05	0.000332	CcSEcCtD
Paclitaxel—Decreased appetite—Lisinopril—systemic scleroderma	9.81e-05	0.000331	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Lisinopril—systemic scleroderma	9.75e-05	0.000329	CcSEcCtD
Paclitaxel—Fatigue—Lisinopril—systemic scleroderma	9.73e-05	0.000328	CcSEcCtD
Paclitaxel—Shock—Mycophenolate mofetil—systemic scleroderma	9.73e-05	0.000328	CcSEcCtD
Paclitaxel—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	9.7e-05	0.000327	CcSEcCtD
Paclitaxel—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	9.68e-05	0.000327	CcSEcCtD
Paclitaxel—Hypersensitivity—Leflunomide—systemic scleroderma	9.68e-05	0.000327	CcSEcCtD
Paclitaxel—Pancreatitis—Methotrexate—systemic scleroderma	9.66e-05	0.000326	CcSEcCtD
Paclitaxel—Pain—Lisinopril—systemic scleroderma	9.65e-05	0.000326	CcSEcCtD
Paclitaxel—Constipation—Lisinopril—systemic scleroderma	9.65e-05	0.000326	CcSEcCtD
Paclitaxel—Tachycardia—Mycophenolate mofetil—systemic scleroderma	9.65e-05	0.000326	CcSEcCtD
Paclitaxel—Skin disorder—Mycophenolate mofetil—systemic scleroderma	9.61e-05	0.000324	CcSEcCtD
Paclitaxel—Bradycardia—Prednisone—systemic scleroderma	9.61e-05	0.000324	CcSEcCtD
Paclitaxel—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	9.56e-05	0.000323	CcSEcCtD
Paclitaxel—Diarrhoea—Azathioprine—systemic scleroderma	9.52e-05	0.000321	CcSEcCtD
Paclitaxel—Haemoglobin—Prednisone—systemic scleroderma	9.48e-05	0.00032	CcSEcCtD
Paclitaxel—Nausea—Captopril—systemic scleroderma	9.47e-05	0.00032	CcSEcCtD
Paclitaxel—Haemorrhage—Prednisone—systemic scleroderma	9.44e-05	0.000318	CcSEcCtD
Paclitaxel—Anorexia—Mycophenolate mofetil—systemic scleroderma	9.43e-05	0.000318	CcSEcCtD
Paclitaxel—Asthenia—Leflunomide—systemic scleroderma	9.43e-05	0.000318	CcSEcCtD
Paclitaxel—Pancytopenia—Methotrexate—systemic scleroderma	9.36e-05	0.000316	CcSEcCtD
Paclitaxel—Feeling abnormal—Lisinopril—systemic scleroderma	9.3e-05	0.000314	CcSEcCtD
Paclitaxel—Pruritus—Leflunomide—systemic scleroderma	9.29e-05	0.000314	CcSEcCtD
Paclitaxel—Connective tissue disorder—Prednisone—systemic scleroderma	9.27e-05	0.000313	CcSEcCtD
Paclitaxel—Hypotension—Mycophenolate mofetil—systemic scleroderma	9.24e-05	0.000312	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Lisinopril—systemic scleroderma	9.23e-05	0.000312	CcSEcCtD
Paclitaxel—Dysuria—Methotrexate—systemic scleroderma	9.21e-05	0.000311	CcSEcCtD
Paclitaxel—Neutropenia—Methotrexate—systemic scleroderma	9.21e-05	0.000311	CcSEcCtD
Paclitaxel—Dizziness—Azathioprine—systemic scleroderma	9.2e-05	0.00031	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Methotrexate—systemic scleroderma	9.16e-05	0.000309	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	9.01e-05	0.000304	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Methotrexate—systemic scleroderma	8.99e-05	0.000304	CcSEcCtD
Paclitaxel—Asthenia—Mycophenolic acid—systemic scleroderma	8.99e-05	0.000303	CcSEcCtD
Paclitaxel—Diarrhoea—Leflunomide—systemic scleroderma	8.99e-05	0.000303	CcSEcCtD
Paclitaxel—Urticaria—Lisinopril—systemic scleroderma	8.97e-05	0.000303	CcSEcCtD
Paclitaxel—Insomnia—Mycophenolate mofetil—systemic scleroderma	8.95e-05	0.000302	CcSEcCtD
Paclitaxel—Abdominal pain—Lisinopril—systemic scleroderma	8.92e-05	0.000301	CcSEcCtD
Paclitaxel—Body temperature increased—Lisinopril—systemic scleroderma	8.92e-05	0.000301	CcSEcCtD
Paclitaxel—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	8.88e-05	0.0003	CcSEcCtD
Paclitaxel—Pruritus—Mycophenolic acid—systemic scleroderma	8.87e-05	0.000299	CcSEcCtD
Paclitaxel—Vomiting—Azathioprine—systemic scleroderma	8.84e-05	0.000299	CcSEcCtD
Paclitaxel—Pneumonia—Methotrexate—systemic scleroderma	8.84e-05	0.000298	CcSEcCtD
Paclitaxel—Eye disorder—Prednisone—systemic scleroderma	8.82e-05	0.000298	CcSEcCtD
Paclitaxel—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	8.82e-05	0.000298	CcSEcCtD
Paclitaxel—Somnolence—Mycophenolate mofetil—systemic scleroderma	8.79e-05	0.000297	CcSEcCtD
Paclitaxel—Infestation—Methotrexate—systemic scleroderma	8.78e-05	0.000296	CcSEcCtD
Paclitaxel—Infestation NOS—Methotrexate—systemic scleroderma	8.78e-05	0.000296	CcSEcCtD
Paclitaxel—Rash—Azathioprine—systemic scleroderma	8.77e-05	0.000296	CcSEcCtD
Paclitaxel—Dermatitis—Azathioprine—systemic scleroderma	8.76e-05	0.000296	CcSEcCtD
Paclitaxel—Depression—Methotrexate—systemic scleroderma	8.76e-05	0.000296	CcSEcCtD
Paclitaxel—Flushing—Prednisone—systemic scleroderma	8.76e-05	0.000296	CcSEcCtD
Paclitaxel—Headache—Azathioprine—systemic scleroderma	8.71e-05	0.000294	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	8.71e-05	0.000294	CcSEcCtD
Paclitaxel—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	8.71e-05	0.000294	CcSEcCtD
Paclitaxel—Dizziness—Leflunomide—systemic scleroderma	8.69e-05	0.000293	CcSEcCtD
Paclitaxel—Renal failure—Methotrexate—systemic scleroderma	8.64e-05	0.000291	CcSEcCtD
Paclitaxel—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	8.6e-05	0.00029	CcSEcCtD
Paclitaxel—Diarrhoea—Mycophenolic acid—systemic scleroderma	8.57e-05	0.000289	CcSEcCtD
Paclitaxel—Stomatitis—Methotrexate—systemic scleroderma	8.56e-05	0.000289	CcSEcCtD
Paclitaxel—Angiopathy—Prednisone—systemic scleroderma	8.56e-05	0.000289	CcSEcCtD
Paclitaxel—Conjunctivitis—Methotrexate—systemic scleroderma	8.54e-05	0.000288	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	8.54e-05	0.000288	CcSEcCtD
Paclitaxel—Immune system disorder—Prednisone—systemic scleroderma	8.52e-05	0.000288	CcSEcCtD
Paclitaxel—Pain—Mycophenolate mofetil—systemic scleroderma	8.46e-05	0.000285	CcSEcCtD
Paclitaxel—Constipation—Mycophenolate mofetil—systemic scleroderma	8.46e-05	0.000285	CcSEcCtD
Paclitaxel—Arrhythmia—Prednisone—systemic scleroderma	8.43e-05	0.000285	CcSEcCtD
Paclitaxel—Haematuria—Methotrexate—systemic scleroderma	8.38e-05	0.000283	CcSEcCtD
Paclitaxel—Vomiting—Leflunomide—systemic scleroderma	8.35e-05	0.000282	CcSEcCtD
Paclitaxel—Alopecia—Prednisone—systemic scleroderma	8.34e-05	0.000281	CcSEcCtD
Paclitaxel—Hypersensitivity—Lisinopril—systemic scleroderma	8.32e-05	0.000281	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Methotrexate—systemic scleroderma	8.31e-05	0.00028	CcSEcCtD
Paclitaxel—Dizziness—Mycophenolic acid—systemic scleroderma	8.29e-05	0.00028	CcSEcCtD
Paclitaxel—Epistaxis—Methotrexate—systemic scleroderma	8.29e-05	0.00028	CcSEcCtD
Paclitaxel—Rash—Leflunomide—systemic scleroderma	8.28e-05	0.00028	CcSEcCtD
Paclitaxel—Dermatitis—Leflunomide—systemic scleroderma	8.28e-05	0.000279	CcSEcCtD
Paclitaxel—Mental disorder—Prednisone—systemic scleroderma	8.27e-05	0.000279	CcSEcCtD
Paclitaxel—Nausea—Azathioprine—systemic scleroderma	8.26e-05	0.000279	CcSEcCtD
Paclitaxel—Headache—Leflunomide—systemic scleroderma	8.23e-05	0.000278	CcSEcCtD
Paclitaxel—Erythema—Prednisone—systemic scleroderma	8.21e-05	0.000277	CcSEcCtD
Paclitaxel—Malnutrition—Prednisone—systemic scleroderma	8.21e-05	0.000277	CcSEcCtD
Paclitaxel—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	8.15e-05	0.000275	CcSEcCtD
Paclitaxel—Asthenia—Lisinopril—systemic scleroderma	8.1e-05	0.000273	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	8.09e-05	0.000273	CcSEcCtD
Paclitaxel—Pruritus—Lisinopril—systemic scleroderma	7.99e-05	0.00027	CcSEcCtD
Paclitaxel—Vomiting—Mycophenolic acid—systemic scleroderma	7.97e-05	0.000269	CcSEcCtD
Paclitaxel—Haemoglobin—Methotrexate—systemic scleroderma	7.93e-05	0.000268	CcSEcCtD
Paclitaxel—Rash—Mycophenolic acid—systemic scleroderma	7.9e-05	0.000267	CcSEcCtD
Paclitaxel—Dermatitis—Mycophenolic acid—systemic scleroderma	7.89e-05	0.000266	CcSEcCtD
Paclitaxel—Haemorrhage—Methotrexate—systemic scleroderma	7.89e-05	0.000266	CcSEcCtD
Paclitaxel—Urticaria—Mycophenolate mofetil—systemic scleroderma	7.86e-05	0.000265	CcSEcCtD
Paclitaxel—Headache—Mycophenolic acid—systemic scleroderma	7.85e-05	0.000265	CcSEcCtD
Paclitaxel—Pharyngitis—Methotrexate—systemic scleroderma	7.83e-05	0.000264	CcSEcCtD
Paclitaxel—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	7.82e-05	0.000264	CcSEcCtD
Paclitaxel—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	7.82e-05	0.000264	CcSEcCtD
Paclitaxel—Nausea—Leflunomide—systemic scleroderma	7.8e-05	0.000263	CcSEcCtD
Paclitaxel—Urinary tract disorder—Methotrexate—systemic scleroderma	7.79e-05	0.000263	CcSEcCtD
Paclitaxel—Vision blurred—Prednisone—systemic scleroderma	7.74e-05	0.000261	CcSEcCtD
Paclitaxel—Urethral disorder—Methotrexate—systemic scleroderma	7.73e-05	0.000261	CcSEcCtD
Paclitaxel—Diarrhoea—Lisinopril—systemic scleroderma	7.72e-05	0.000261	CcSEcCtD
Paclitaxel—Ill-defined disorder—Prednisone—systemic scleroderma	7.62e-05	0.000257	CcSEcCtD
Paclitaxel—Visual impairment—Methotrexate—systemic scleroderma	7.6e-05	0.000256	CcSEcCtD
Paclitaxel—Anaemia—Prednisone—systemic scleroderma	7.59e-05	0.000256	CcSEcCtD
Paclitaxel—Agitation—Prednisone—systemic scleroderma	7.55e-05	0.000255	CcSEcCtD
Paclitaxel—Angioedema—Prednisone—systemic scleroderma	7.51e-05	0.000253	CcSEcCtD
Paclitaxel—Dizziness—Lisinopril—systemic scleroderma	7.46e-05	0.000252	CcSEcCtD
Paclitaxel—Erythema multiforme—Methotrexate—systemic scleroderma	7.46e-05	0.000252	CcSEcCtD
Paclitaxel—Nausea—Mycophenolic acid—systemic scleroderma	7.44e-05	0.000251	CcSEcCtD
Paclitaxel—Malaise—Prednisone—systemic scleroderma	7.41e-05	0.00025	CcSEcCtD
Paclitaxel—Vertigo—Prednisone—systemic scleroderma	7.38e-05	0.000249	CcSEcCtD
Paclitaxel—Eye disorder—Methotrexate—systemic scleroderma	7.37e-05	0.000249	CcSEcCtD
Paclitaxel—Syncope—Prednisone—systemic scleroderma	7.37e-05	0.000249	CcSEcCtD
Paclitaxel—Tinnitus—Methotrexate—systemic scleroderma	7.35e-05	0.000248	CcSEcCtD
Paclitaxel—Cardiac disorder—Methotrexate—systemic scleroderma	7.32e-05	0.000247	CcSEcCtD
Paclitaxel—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	7.29e-05	0.000246	CcSEcCtD
Paclitaxel—Loss of consciousness—Prednisone—systemic scleroderma	7.22e-05	0.000244	CcSEcCtD
Paclitaxel—Vomiting—Lisinopril—systemic scleroderma	7.18e-05	0.000242	CcSEcCtD
Paclitaxel—Angiopathy—Methotrexate—systemic scleroderma	7.15e-05	0.000241	CcSEcCtD
Paclitaxel—Immune system disorder—Methotrexate—systemic scleroderma	7.12e-05	0.00024	CcSEcCtD
Paclitaxel—Rash—Lisinopril—systemic scleroderma	7.12e-05	0.00024	CcSEcCtD
Paclitaxel—Convulsion—Prednisone—systemic scleroderma	7.12e-05	0.00024	CcSEcCtD
Paclitaxel—Dermatitis—Lisinopril—systemic scleroderma	7.11e-05	0.00024	CcSEcCtD
Paclitaxel—Mediastinal disorder—Methotrexate—systemic scleroderma	7.11e-05	0.00024	CcSEcCtD
Paclitaxel—Asthenia—Mycophenolate mofetil—systemic scleroderma	7.1e-05	0.000239	CcSEcCtD
Paclitaxel—Hypertension—Prednisone—systemic scleroderma	7.09e-05	0.000239	CcSEcCtD
Paclitaxel—Chills—Methotrexate—systemic scleroderma	7.08e-05	0.000239	CcSEcCtD
Paclitaxel—Headache—Lisinopril—systemic scleroderma	7.07e-05	0.000239	CcSEcCtD
Paclitaxel—Pruritus—Mycophenolate mofetil—systemic scleroderma	7e-05	0.000236	CcSEcCtD
Paclitaxel—Arthralgia—Prednisone—systemic scleroderma	6.99e-05	0.000236	CcSEcCtD
Paclitaxel—Myalgia—Prednisone—systemic scleroderma	6.99e-05	0.000236	CcSEcCtD
Paclitaxel—Anxiety—Prednisone—systemic scleroderma	6.97e-05	0.000235	CcSEcCtD
Paclitaxel—Alopecia—Methotrexate—systemic scleroderma	6.97e-05	0.000235	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	6.95e-05	0.000234	CcSEcCtD
Paclitaxel—Discomfort—Prednisone—systemic scleroderma	6.91e-05	0.000233	CcSEcCtD
Paclitaxel—Mental disorder—Methotrexate—systemic scleroderma	6.91e-05	0.000233	CcSEcCtD
Paclitaxel—Malnutrition—Methotrexate—systemic scleroderma	6.86e-05	0.000232	CcSEcCtD
Paclitaxel—Erythema—Methotrexate—systemic scleroderma	6.86e-05	0.000232	CcSEcCtD
Paclitaxel—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	6.77e-05	0.000228	CcSEcCtD
Paclitaxel—Dysgeusia—Methotrexate—systemic scleroderma	6.72e-05	0.000227	CcSEcCtD
Paclitaxel—Nausea—Lisinopril—systemic scleroderma	6.7e-05	0.000226	CcSEcCtD
Paclitaxel—Anaphylactic shock—Prednisone—systemic scleroderma	6.7e-05	0.000226	CcSEcCtD
Paclitaxel—Oedema—Prednisone—systemic scleroderma	6.7e-05	0.000226	CcSEcCtD
Paclitaxel—Infection—Prednisone—systemic scleroderma	6.66e-05	0.000225	CcSEcCtD
Paclitaxel—Back pain—Methotrexate—systemic scleroderma	6.64e-05	0.000224	CcSEcCtD
Paclitaxel—Shock—Prednisone—systemic scleroderma	6.6e-05	0.000223	CcSEcCtD
Paclitaxel—Nervous system disorder—Prednisone—systemic scleroderma	6.57e-05	0.000222	CcSEcCtD
Paclitaxel—Tachycardia—Prednisone—systemic scleroderma	6.54e-05	0.000221	CcSEcCtD
Paclitaxel—Dizziness—Mycophenolate mofetil—systemic scleroderma	6.54e-05	0.000221	CcSEcCtD
Paclitaxel—Skin disorder—Prednisone—systemic scleroderma	6.51e-05	0.00022	CcSEcCtD
Paclitaxel—Hyperhidrosis—Prednisone—systemic scleroderma	6.48e-05	0.000219	CcSEcCtD
Paclitaxel—Vision blurred—Methotrexate—systemic scleroderma	6.47e-05	0.000218	CcSEcCtD
Paclitaxel—Anorexia—Prednisone—systemic scleroderma	6.39e-05	0.000216	CcSEcCtD
Paclitaxel—Ill-defined disorder—Methotrexate—systemic scleroderma	6.37e-05	0.000215	CcSEcCtD
Paclitaxel—Anaemia—Methotrexate—systemic scleroderma	6.35e-05	0.000214	CcSEcCtD
Paclitaxel—Vomiting—Mycophenolate mofetil—systemic scleroderma	6.29e-05	0.000212	CcSEcCtD
Paclitaxel—Rash—Mycophenolate mofetil—systemic scleroderma	6.24e-05	0.00021	CcSEcCtD
Paclitaxel—Dermatitis—Mycophenolate mofetil—systemic scleroderma	6.23e-05	0.00021	CcSEcCtD
Paclitaxel—Headache—Mycophenolate mofetil—systemic scleroderma	6.2e-05	0.000209	CcSEcCtD
Paclitaxel—Malaise—Methotrexate—systemic scleroderma	6.19e-05	0.000209	CcSEcCtD
Paclitaxel—Vertigo—Methotrexate—systemic scleroderma	6.17e-05	0.000208	CcSEcCtD
Paclitaxel—Leukopenia—Methotrexate—systemic scleroderma	6.14e-05	0.000207	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Prednisone—systemic scleroderma	6.11e-05	0.000206	CcSEcCtD
Paclitaxel—Insomnia—Prednisone—systemic scleroderma	6.06e-05	0.000205	CcSEcCtD
Paclitaxel—Paraesthesia—Prednisone—systemic scleroderma	6.02e-05	0.000203	CcSEcCtD
Paclitaxel—Cough—Methotrexate—systemic scleroderma	5.99e-05	0.000202	CcSEcCtD
Paclitaxel—Convulsion—Methotrexate—systemic scleroderma	5.95e-05	0.000201	CcSEcCtD
Paclitaxel—Dyspepsia—Prednisone—systemic scleroderma	5.9e-05	0.000199	CcSEcCtD
Paclitaxel—Nausea—Mycophenolate mofetil—systemic scleroderma	5.87e-05	0.000198	CcSEcCtD
Paclitaxel—Chest pain—Methotrexate—systemic scleroderma	5.84e-05	0.000197	CcSEcCtD
Paclitaxel—Arthralgia—Methotrexate—systemic scleroderma	5.84e-05	0.000197	CcSEcCtD
Paclitaxel—Myalgia—Methotrexate—systemic scleroderma	5.84e-05	0.000197	CcSEcCtD
Paclitaxel—Decreased appetite—Prednisone—systemic scleroderma	5.83e-05	0.000197	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	5.8e-05	0.000196	CcSEcCtD
Paclitaxel—Fatigue—Prednisone—systemic scleroderma	5.78e-05	0.000195	CcSEcCtD
Paclitaxel—Discomfort—Methotrexate—systemic scleroderma	5.77e-05	0.000195	CcSEcCtD
Paclitaxel—Constipation—Prednisone—systemic scleroderma	5.73e-05	0.000193	CcSEcCtD
Paclitaxel—Confusional state—Methotrexate—systemic scleroderma	5.65e-05	0.000191	CcSEcCtD
Paclitaxel—Anaphylactic shock—Methotrexate—systemic scleroderma	5.6e-05	0.000189	CcSEcCtD
Paclitaxel—Infection—Methotrexate—systemic scleroderma	5.57e-05	0.000188	CcSEcCtD
Paclitaxel—Feeling abnormal—Prednisone—systemic scleroderma	5.52e-05	0.000186	CcSEcCtD
Paclitaxel—Nervous system disorder—Methotrexate—systemic scleroderma	5.49e-05	0.000185	CcSEcCtD
Paclitaxel—Thrombocytopenia—Methotrexate—systemic scleroderma	5.49e-05	0.000185	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Prednisone—systemic scleroderma	5.48e-05	0.000185	CcSEcCtD
Paclitaxel—Skin disorder—Methotrexate—systemic scleroderma	5.44e-05	0.000184	CcSEcCtD
Paclitaxel—Hyperhidrosis—Methotrexate—systemic scleroderma	5.42e-05	0.000183	CcSEcCtD
Paclitaxel—Anorexia—Methotrexate—systemic scleroderma	5.34e-05	0.00018	CcSEcCtD
Paclitaxel—Urticaria—Prednisone—systemic scleroderma	5.33e-05	0.00018	CcSEcCtD
Paclitaxel—Abdominal pain—Prednisone—systemic scleroderma	5.3e-05	0.000179	CcSEcCtD
Paclitaxel—Body temperature increased—Prednisone—systemic scleroderma	5.3e-05	0.000179	CcSEcCtD
Paclitaxel—Hypotension—Methotrexate—systemic scleroderma	5.24e-05	0.000177	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	5.1e-05	0.000172	CcSEcCtD
Paclitaxel—Insomnia—Methotrexate—systemic scleroderma	5.07e-05	0.000171	CcSEcCtD
Paclitaxel—Paraesthesia—Methotrexate—systemic scleroderma	5.03e-05	0.00017	CcSEcCtD
Paclitaxel—Dyspnoea—Methotrexate—systemic scleroderma	5e-05	0.000169	CcSEcCtD
Paclitaxel—Somnolence—Methotrexate—systemic scleroderma	4.98e-05	0.000168	CcSEcCtD
Paclitaxel—Hypersensitivity—Prednisone—systemic scleroderma	4.94e-05	0.000167	CcSEcCtD
Paclitaxel—Dyspepsia—Methotrexate—systemic scleroderma	4.93e-05	0.000166	CcSEcCtD
Paclitaxel—Decreased appetite—Methotrexate—systemic scleroderma	4.87e-05	0.000164	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Methotrexate—systemic scleroderma	4.84e-05	0.000163	CcSEcCtD
Paclitaxel—Fatigue—Methotrexate—systemic scleroderma	4.83e-05	0.000163	CcSEcCtD
Paclitaxel—Asthenia—Prednisone—systemic scleroderma	4.81e-05	0.000162	CcSEcCtD
Paclitaxel—Pain—Methotrexate—systemic scleroderma	4.79e-05	0.000162	CcSEcCtD
Paclitaxel—Pruritus—Prednisone—systemic scleroderma	4.74e-05	0.00016	CcSEcCtD
Paclitaxel—Feeling abnormal—Methotrexate—systemic scleroderma	4.62e-05	0.000156	CcSEcCtD
Paclitaxel—Diarrhoea—Prednisone—systemic scleroderma	4.59e-05	0.000155	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Methotrexate—systemic scleroderma	4.58e-05	0.000155	CcSEcCtD
Paclitaxel—Urticaria—Methotrexate—systemic scleroderma	4.45e-05	0.00015	CcSEcCtD
Paclitaxel—Dizziness—Prednisone—systemic scleroderma	4.43e-05	0.00015	CcSEcCtD
Paclitaxel—Abdominal pain—Methotrexate—systemic scleroderma	4.43e-05	0.000149	CcSEcCtD
Paclitaxel—Body temperature increased—Methotrexate—systemic scleroderma	4.43e-05	0.000149	CcSEcCtD
Paclitaxel—Vomiting—Prednisone—systemic scleroderma	4.26e-05	0.000144	CcSEcCtD
Paclitaxel—Rash—Prednisone—systemic scleroderma	4.23e-05	0.000143	CcSEcCtD
Paclitaxel—Dermatitis—Prednisone—systemic scleroderma	4.22e-05	0.000143	CcSEcCtD
Paclitaxel—Headache—Prednisone—systemic scleroderma	4.2e-05	0.000142	CcSEcCtD
Paclitaxel—Hypersensitivity—Methotrexate—systemic scleroderma	4.13e-05	0.000139	CcSEcCtD
Paclitaxel—Asthenia—Methotrexate—systemic scleroderma	4.02e-05	0.000136	CcSEcCtD
Paclitaxel—Nausea—Prednisone—systemic scleroderma	3.98e-05	0.000134	CcSEcCtD
Paclitaxel—Pruritus—Methotrexate—systemic scleroderma	3.96e-05	0.000134	CcSEcCtD
Paclitaxel—Diarrhoea—Methotrexate—systemic scleroderma	3.83e-05	0.000129	CcSEcCtD
Paclitaxel—Dizziness—Methotrexate—systemic scleroderma	3.7e-05	0.000125	CcSEcCtD
Paclitaxel—Vomiting—Methotrexate—systemic scleroderma	3.56e-05	0.00012	CcSEcCtD
Paclitaxel—Rash—Methotrexate—systemic scleroderma	3.53e-05	0.000119	CcSEcCtD
Paclitaxel—Dermatitis—Methotrexate—systemic scleroderma	3.53e-05	0.000119	CcSEcCtD
Paclitaxel—Headache—Methotrexate—systemic scleroderma	3.51e-05	0.000118	CcSEcCtD
Paclitaxel—Nausea—Methotrexate—systemic scleroderma	3.33e-05	0.000112	CcSEcCtD
